2,454 followers
Zanubrutinib for the treatment of lymphoid malignancies: Current status and future directions #lymphoma #lymsm https://t.co/YwgdnNGEJ8
Zanubrutinib for the treatment of lymphoid malignancies: Current status and future directions #lymphoma #lymsm https://t.co/YwgdnNGEJ8
Zanubrutinib for the treatment of lymphoid malignancies: Current status and future directions #lymphoma #lymsm https://t.co/tp4kImhht3
New research: Zanubrutinib for the treatment of lymphoid malignancies: Current status and future directions: Zanubrutinib (BGB-3111, Brukinsa®, BeiGene) is a next-generation irreversible inhibitor of Bruton’s tyrosine kinase (BTK), developed by… https://t.